Treosulfan is an effective alkylating cytostatic for malignant melanoma in vitro and in vivo
- 1 April 1999
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Melanoma Research
- Vol. 9 (2), 125-132
- https://doi.org/10.1097/00008390-199904000-00003